Non-Invasive Positive Pressure Ventilation (NIPPV) in the Pregnant Patient: A Case Series

摘要

Rationale: Acute respiratory failure is an uncommon complication of pregnancy. However, it is the most frequent organ dysfunction associated with obstetric admissions to an intensive care unit. The obstetric population is a different group due to its physiology and the presence of the fetus that lacks evidence in the literature within the subject of ventilatory support. Noninvasive positive pressure ventilation (NIPPV) is often avoided due to the lack of knowledge on the safety and efficacy of this modality. Currently, there are no guidelines for the management of respiratory failure in pregnancy. Objectives: To provide evidence in support of the use of NIPPV as a safe and reasonable modality for pregnant patients with respiratory failure. Methods: We retrospectively reviewed medical records of 29 pregnant patients of the Obstetric Critical Care Unit of a tertiary hospital in Panamá City who received NIPPV from 2013 to 2015. Failure to response was defined as the lack of increase in the style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">pa>> style="font-family:""> style="font-family:Verdana;">O _{style="font-family:Verdana;">2} style="font-family:Verdana;">/FiO _{style="font-family:Verdana;">2} style="font-family:Verdana;"> ratio or clinical deterioration 6 hours after initiating NIPPV. Demographics, indication for NIPPV, duration of treatment, as well as maternal and fetal outcomes were collected. style="font-family:Verdana;">Measurements style="font-family:Verdana;">and style="font-family:Verdana;">Main style="font-family:Verdana;">Results: style="font-family:Verdana;">Mean age was 28.4 ± 6 years, mean body mass index 27.4 ± 3.3, and mean gestational age at admission was 30 style="font-family:Verdana;">5/7 style="font-family:Verdana;"> ± 5 weeks. Twenty-four patients (82.8%) met the criteria for acute lung injury (ALI) and an additional two (6.9%) for acute respiratory distress syndrome (ARDS). The mean duration of ventilation was 50.6 ± 17.27 hours. Statistically significant differences were noted between the style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">pa>> style="font-family:""> style="font-family:Verdana;">O _{style="font-family:Verdana;">2} style="font-family:Verdana;">/FiO _{style="font-family:Verdana;">2} style="font-family:Verdana;"> ratios in failure and successful patients within 2 hours of NIPPV therapy (P = 0.007) and style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">pa>> style="font-family:""> style="font-family:Verdana;">O _{style="font-family:Verdana;">2} style="font-family:Verdana;">/FiO _{style="font-family:Verdana;">2} style="font-family:Verdana;"> ratio within 6 hours of NIPPV therapy (P = 0.03). Success was defined when the patient was administered NIPPV, resulting in an improvement (increase in style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">p>> style="font-family:""> style="font-family:Verdana;">a/FiO _{style="font-family:Verdana;">2} style="font-family:Verdana;"> ratio) of her ventilatory parameters. Three patients (10.3%) failed to respond to NIPPV and needed to be converted to invasive mechanical ventilation. Patients who required intubation had a longer duration of ICU stay (P = 0.006) and overall hospital stay (P = 0.03). NULL of patients presented aspiration during NIPPV therapy. style="font-family:Verdana;">Conclusion: style="font-family:Verdana;">The current series is the largest report of pregnant patients requiring ventilatory support who received NIPPV as first line of therapy. This report shows the usefulness of this ventilation modality, avoiding intubation with its risks, of a significant number of patients, especially ventilator-associated pneumonia.